首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets
【24h】

Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets

机译:通过微环境靶向乳腺癌:寻找相关靶点的临床前和临床研究现状

获取原文
获取原文并翻译 | 示例
           

摘要

It is increasingly evident that not only breast cancer cells, but also the tissue embedding these cells: the tumor microenvironment, plays an important role in tumor progression, metastasis formation and treatment sensitivity. This review focuses on the current knowledge of processes by which the microenvironment affects breast cancer, including formation of the metastatic niche, metabolic stimulation, stimulation of tumor cell migration, immune modulation, angiogenesis and matrix remodeling. The number of drugs targeting key factors in these processes is expanding, and the available clinical data is increasing. Therefore current strategies for intervention and prediction of treatment response are outlined. At present, targeting the formation of the metastatic niche and metabolic stimulation by the breast cancer microenvironment, are already showing clinical efficacy. Intervening in the stimulation of tumor cell migration and immune modulation by the microenvironment upcoming fields of great research interest. In contrast, targeting microenvironmental angiogenesis or matrix remodeling appears to be of limited clinical relevance in breast cancer treatment so far. Further research is warranted to optimize intervention strategies and develop predictive tests for the relevance of targeting involved factors within the microenvironment in order to optimally personalize breast cancer treatment. (C) 2014 Elsevier Inc. All rights reserved.
机译:越来越明显的是,不仅乳腺癌细胞,而且包埋这些细胞的组织:肿瘤微环境在肿瘤进展,转移形成和治疗敏感性中也起着重要作用。这篇综述集中于微环境影响乳腺癌的过程的当前知识,包括转移性生态位的形成,代谢刺激,肿瘤细胞迁移的刺激,免疫调节,血管生成和基质重塑。在这些过程中,针对关键因素的药物数量正在增加,可用的临床数据也在增加。因此,概述了当前用于干预和预测治疗反应的策略。目前,针对转移性小生境的形成和乳腺癌微环境的代谢刺激已经显示出临床功效。通过即将到来的微环境领域介入对肿瘤细胞迁移和免疫调节的刺激,具有极大的研究兴趣。相反,迄今为止,靶向微环境血管生成或基质重塑似乎在乳腺癌治疗中具有有限的临床意义。有必要进行进一步的研究,以优化干预策略并开发针对微环境内靶向因素相关性的预测性测试,以最佳地个性化乳腺癌治疗。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号